亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

合肥賽曼諾生物科技有限公司  

肽核酸,類肽和多肽定制合成服務以及肽核酸單體,類肽單體

搜索
網站公告
合肥賽曼諾生物科技有限公司是專注于固相合成方法學研究的專業化高科技公司。賽曼諾具有多年的固相合成研究開發生產經驗。賽曼諾致力于為全球范圍內的客戶提供包括肽核酸,類肽和多肽定制合成服務以及肽核酸單體,類肽單體。
新聞中心
產品分類
  • 暫無分類
聯系方式
  • 聯系人:周沐
  • 電話:0551-65326643
  • 郵件:info@cellmano.com
  • QQ:1761863581
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > Antho-Rnamide
Antho-Rnamide
單價 面議對比
詢價 暫無
發貨 安徽合肥市付款后3天內
庫存 1000mg起訂5mg
品牌 賽曼諾生物
過期 長期有效
更新 2015-02-13 13:12
 
詳細信息
 
A-1902 Antho-Rfamide C22H32N8O5 488.55 107535-01-3 Pyr-Gly-Arg-Phe-NH2
A-1903 Antho-Rnamide C25H40N8O6 · HCl 585.10 129536-35-2 L-β-Phenyllactoyl-Leu-Arg-Asn-NH2 · HCl
A-1904 Antho-RPamide I C45H75N13O9 · 2 HCl 1015.09 145523-59-7 H-Leu-Pro-Pro-Gly-Pro-Leu-Pro-Arg-Pro-NH2 · 2 HCl
A-1905 Antho-RPamide II C41H60N14O9 · HCl 929.48 352280-38-7 Pyr-Asn-Phe-His-Leu-Arg-Pro-NH2 · HCl
©2025 合肥賽曼諾生物科技有限公司 版權所有   技術支持:化工網   訪問量:7657  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |